Preoperative Occult Neurodegeneration and Postoperative Delirium

术前隐匿性神经变性和术后谵妄

基本信息

  • 批准号:
    10367616
  • 负责人:
  • 金额:
    $ 89.45万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-03-15 至 2027-01-31
  • 项目状态:
    未结题

项目摘要

Program Director/Principal Investigator (Last, First, Middle): Crosby, Gregory J. ABSTRACT Delirium is the most common complication of surgery and anesthesia in older patients, afflicting 15-60% of those having non-cardiac procedures. This is a major clinical problem because nearly 40% of surgical procedures are performed on older patients and delirium is associated with serious morbidity, including accelerated decline to dementia. Still, the cause of postoperative delirium is uncertain and its neuropathogenesis is unknown. Cerebral neurodegenerative pathology characteristic of Alzheimer’s disease and related disorders is common even in cognitively normal older people, and by the time even mild symptoms develop is pronounced. We hypothesize that this preexisting burden of occult cerebral neurodegeneration accounts for enhanced vulnerability to postoperative delirium (Aim 1), augments surgery- and delirium-induced cerebral injury (Aim 2), and fuels surgery- and delirium-induced inflammation, which aggravates neural injury and increases neurodegeneration (Aim 3). We will test these hypotheses in a longitudinal prospective observational study of older surgical patients evaluated preoperatively for cognitive impairment and followed postoperatively for delirium and longer-term cognitive decline, with neurodegeneration and neural injury defined by ultrasensitive plasma biomarkers and cerebral MR imaging. This project is innovative because it addresses the key question of whether surgery and anesthesia produce delirium and persistent cognitive decline de novo or by unmasking or exacerbating a cerebral precondition and is significant because of the magnitude of the clinical problems (neurodegenerative disease, delirium), practicality of the approach (blood- based biomarkers), and potential to improve the outcomes of vulnerable older surgical patients. OMB No. 0925-0001/0002 (Rev. 03/2020 Approved Through 02/28/2023) Page Continuation Format Page
项目负责人/主要研究者(最后一名、第一名、中间名):克罗斯比、Gregory J. 摘要 谵妄是老年患者手术和麻醉最常见的并发症, 非心脏手术的患者。这是一个主要的临床问题,因为近40%的外科手术 手术是对老年患者进行的,谵妄与严重的发病率有关,包括 加速衰退为痴呆症尽管如此,术后谵妄的原因是不确定的, 神经发病机制尚不清楚。阿尔茨海默病的脑神经退行性病变特征 即使在认知正常的老年人中, 发展是显而易见的。我们假设这种先前存在的隐性脑神经变性负担 解释了术后谵妄的易感性增强(目标1),增加了手术和谵妄诱导的 脑损伤(目的2),并刺激手术和谵妄诱导的炎症,从而加重神经损伤 并增加神经变性(目的3)。我们将在一个纵向的前瞻性测试这些假设 对老年手术患者进行术前认知功能障碍评估和随访的观察性研究 术后谵妄和长期认知下降,伴神经变性和神经损伤 通过超灵敏的血浆生物标志物和脑MR成像来定义。这个项目是创新的,因为它 解决了手术和麻醉是否会产生谵妄和持续认知的关键问题, 通过暴露或加重大脑先决条件而从头下降,并且由于 临床问题的严重性(神经退行性疾病,谵妄),方法的实用性(血液- 基于生物标志物),并有可能改善脆弱的老年手术患者的结局。 OMB编号0925-0001/0002(修订版03/2020批准至02/28/2023)页码继续格式页码

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

GREGORY CROSBY其他文献

GREGORY CROSBY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('GREGORY CROSBY', 18)}}的其他基金

Preoperative Occult Neurodegeneration and Postoperative Delirium
术前隐匿性神经变性和术后谵妄
  • 批准号:
    10589054
  • 财政年份:
    2022
  • 资助金额:
    $ 89.45万
  • 项目类别:
Role of ABeta in neural synapse and circuit remodeling following general anesthes
Aβ 在全身麻醉后神经突触和回路重塑中的作用
  • 批准号:
    8778370
  • 财政年份:
    2014
  • 资助金额:
    $ 89.45万
  • 项目类别:
Crosby_Gregory_Mechanisms of Post-Anesthetic CNS Dysfunction in Aging
Crosby_Gregory_衰老过程中麻醉后中枢神经系统功能障碍的机制
  • 批准号:
    7931508
  • 财政年份:
    2009
  • 资助金额:
    $ 89.45万
  • 项目类别:
Mechanisms of Post-Anesthetic CNS Dysfunction in Aging
老年麻醉后中枢神经系统功能障碍的机制
  • 批准号:
    7056069
  • 财政年份:
    2003
  • 资助金额:
    $ 89.45万
  • 项目类别:
Crosby_Gregory_Mechanisms of Post-Anesthetic CNS Dysfunction in Aging
Crosby_Gregory_衰老过程中麻醉后中枢神经系统功能障碍的机制
  • 批准号:
    7581845
  • 财政年份:
    2003
  • 资助金额:
    $ 89.45万
  • 项目类别:
Mechanisms of Post-Anesthetic CNS Dysfunction in Aging
老年麻醉后中枢神经系统功能障碍的机制
  • 批准号:
    6729968
  • 财政年份:
    2003
  • 资助金额:
    $ 89.45万
  • 项目类别:
Crosby_Gregory_Mechanisms of Post-Anesthetic CNS Dysfunction in Aging
Crosby_Gregory_衰老过程中麻醉后中枢神经系统功能障碍的机制
  • 批准号:
    8056059
  • 财政年份:
    2003
  • 资助金额:
    $ 89.45万
  • 项目类别:
Crosby_Gregory_Mechanisms of Post-Anesthetic CNS Dysfunction in Aging
Crosby_Gregory_衰老过程中麻醉后中枢神经系统功能障碍的机制
  • 批准号:
    8245821
  • 财政年份:
    2003
  • 资助金额:
    $ 89.45万
  • 项目类别:
Mechanisms of Post-Anesthetic CNS Dysfunction in Aging
老年麻醉后中枢神经系统功能障碍的机制
  • 批准号:
    6883148
  • 财政年份:
    2003
  • 资助金额:
    $ 89.45万
  • 项目类别:
Crosby_Gregory_Mechanisms of Post-Anesthetic CNS Dysfunction in Aging
Crosby_Gregory_衰老过程中麻醉后中枢神经系统功能障碍的机制
  • 批准号:
    7774385
  • 财政年份:
    2003
  • 资助金额:
    $ 89.45万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 89.45万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 89.45万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 89.45万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 89.45万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 89.45万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 89.45万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 89.45万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 89.45万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 89.45万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 89.45万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了